|
The Life Sciences sector is experiencing significant growth in the State of Indiana and the City of Noblesville, driven by the rapid evolution of complex modalities. This unprecedented pace of change has resulted in record venture capital financing in the Life Sciences Innovation sector, particularly in gene/cell therapy, biopharma, and consumer health companies.
Noblesville's proximity to Chicago, the third-largest health tech startup community housing 422 health tech company headquarters, adds to its appeal. With a similar Midwest climate and offering a combination of affordability, smart growth, and an unmatched urban/suburban quality of life, Noblesville provides an ideal location for life sciences companies. In 2021, the State of Indiana witnessed over $12.7 billion in pharmaceutical manufactured exports, marking a 20% increase from 2020 and establishing it as the third-ranked state in the nation for such exports (source: BioCrossroads and State HS Database).
|
Learn why specific industries choose Noblesville:
|
|
|
|
|
|
|
